ClinConnect ClinConnect Logo
Search / Trial NCT01518218

Effectiveness of Laying-on-of-hands for Sickle Cell Disease

Launched by MOA HEALTH SCIENCE FOUNDATION · Jan 21, 2012

Trial Information

Current as of June 03, 2025

Completed

Keywords

Sickle Cell Disease Laying On Of Hands Morbidity Mortality

ClinConnect Summary

Patients with sickle cell disease (SCD) have a high risk of premature death in Africa, mainly due to insufficient medical services. SCD patients often visit emergency department and need hospitalization when they suffer from severe pain; however, they manage most of painful episodes at home. Appropriate pain management at home is, therefore, crucial to improve their clinical course and quality of life. Laying-on-of-hands may be a good candidate for home care management, because family member(s) can become a practitioner of laying-on-of-hands without difficulty and administer it to their lov...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients with symptoms associated with sickle cell disease
  • those able to receive laying-on-of-hands every weekday for 1 year
  • those able to receive conventional medical treatment whenever necessary
  • those able to receive blood test at the beginning, after 6 month and after 1 year
  • Exclusion Criteria:
  • those who wish to use other complementary and alternative therapies along with laying-on-of-hands

About Moa Health Science Foundation

Moa Health Science Foundation is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on collaboration and scientific rigor, the foundation supports a variety of clinical studies aimed at addressing unmet medical needs across multiple therapeutic areas. By leveraging a network of experienced researchers and healthcare professionals, Moa Health Science Foundation strives to facilitate the development of safe and effective treatments that enhance the quality of life for patients worldwide.

Locations

Kinshasa, , Congo, The Democratic Republic Of The

Patients applied

0 patients applied

Trial Officials

Kodondi K Koto, MD, PhD

Study Director

The Institute of Scientific Research for Health, Kinshasa

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials